The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?

Background: A National human papilloma virus (HPV) Vaccination Programme for the prevention of HPV infection and associated disease using the quadrivalent HPV vaccine (4vHPV) has been funded and implemented in Australia since 2007, initially for girls only and extended to boys in 2013, with uptake r...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Cyra, Brotherton, Julia ML, Pillsbury, Alexis, Jayasinghe, Sanjay, Donovan, Basil, Macartney, Kristine, Marshall, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194907/
https://www.ncbi.nlm.nih.gov/pubmed/30326995
http://dx.doi.org/10.2807/1560-7917.ES.2018.23.41.1700737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194907/
https://www.ncbi.nlm.nih.gov/pubmed/30326995
http://dx.doi.org/10.2807/1560-7917.ES.2018.23.41.1700737

Ejemplares similares